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Оваа ста тија е со отворен пристап дистрибуирана 
под ус ловите на Нелокализирана лиценца, која 
овозмо жува неограничена употреба, дистрибуци-
ја и репродукција на било кој медиум, доколку се 
цитираат оригиналниот(ите) автор(и) и изворот.
Конкурентски интереси: Авторот изјавува дека 
нема конкурентски интереси
Тироидните карциноми (ТК) се најчестите ендокринолошки тумори со околу 1% учество во сите малиг-
номи, според епидемиолошките податоци. Поради недостаток на публикации кои се однесуваат на 
епидемиолошките трендови за ТК во последните декади во нашата земја, особено по воведување на 
корекцијата во јодната профилакса со повисока доза на јодна суплементација од 1999, сe јави потреба 
од публикување на реален научен увид во епидемиолошката ситуација. Цел на студијата е да се презен-
тираат епидемиолошки податоци за инциденција и преваленција на ТК во Р. Македонија за периодот 
од 1999 до 2010 година. Материјали и методи: Спроведовме ретроспективна анализа на медицинските 
податоци од сите дијагностицирани и лекувани пациенти со ТК на Институтот за патофизиологија и 
нуклеарна медицина (ИПНМ). Поради фактот што во соодветниот период ИПНМ беше единствен цен-
тар за радиојодна терапија на ТК, сметаме дека регистрираните епидемиолошки податоци се репре-
зентативни за состојбата на целата земја. Податоците од Државниот завод за статистика за пописот 
од 1994 и 2002 година ги употребивме за пресметка на годишната инциденција и преваленција, како 
и за анализа на географската и етничката дистрибуција на ТК. Резултати: Со анализа на 12 годишни-
от период вкупно беа детектирани 204 случаи на ТК, односно преваленција од 10,15/105. Највисока 
годишна инциденција е во 2000 година (1,18/105), а најниска во 2003 (0,49/105), континуиран пораст на 
инциденцијата се детектира во периодот  2006 - 2010 со просечна инциденција од 0,98/105. Резултатите 
укажуваат на слична дистрибуција меѓу етничките групи, а регионалната дистрибуција укажа на најви-
сока преваленца во Скопски, Источен и Северноисточен регион, а најниска во Полошки, Југоисточен и 
Пелагониски регион. Заклучок: Според анализираните податоци за периодот 1999-2010, детектиран е 
пораст во инциденцијата и преваленцијата во нашата земја, но сепак пониски споредено со податоците 
од литературата. Не е утврдена значајна разлика во морбидитетот во однос на етничката дистрибуција, 
додека во однос на географската дистрибуција на ТК во осумте региони, констатирана е највисока пре-
валенција во северни и источни региони, а пониска во западните региони. Потребни се понатамошни 
анализи за споредба со претходните епидемиолошки податоци во земјава, како и анализа за можни 
влијанија на  фактори на околината во ниската инциденција, споредено со податоците од литературата.
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Epidemiological data indicates that thyroid carcinoma (TC) is the most frequent endocrinological 
tumors, participating with around 1% from all malignomas. Because of lack of published papers 
related to the epidemiological data for TC in the last two decades in our country especially after the 
introduction of corrected Iodine prophylaxis program, with new higher Iodine supplementation in 
1999, there is a need for publishing real scientific view of the epidemiological situations. The aim of 
the study was to present epidemiological data on incidence and prevalence rate of TC in R Macedonia 
for the period 1999-2010. Materials and methods: A retrospective analysis of medical data from all 
diagnosed and treated TC at the Institute of Pathophysiology and Nuclear Medicine during the period 
1999-2010 was performed. The Institute is the only Center performing treatment of TC with 131I, 
therefore the registered epidemiological data are representative for the country. Statistical State 
Office data from the census in 1994 and 2002 were used to calculate annual incidence and prevalence 
rate as well as geographical and ethnic country distribution of TC. Results: During 12-year period, a 
total of 204 TC cases were registered, with prevalence rate of 10.15/105. The highest incidence rate 
was detected in 2000 (1.18/105) followed by reduction in 2003 (0,49/105). Annual incidence rate showed 
continuously higher incidence rate in the period 2006-2010 with average incidence rate of 0.98/105. 
Results indicate quite similar incidence rate among the three ethnic groups while the regional 
distribution indicates the highest prevalence in Skopje region, East and Northeast region than 
Southwest region. The lowest prevalence rate was registered in Polog, Southeast and Pelagonia region. 
Conclusions: According to the analyzed data from the diagnosed patients with TC during the period 
1999 – 2010, there is increase in the incidence and prevalence rate, but however compared with the 
literature is still very low. Major differences in morbidity rate concerning the ethnic distribution were 
not found. Related to the geographical distribution of TC in eight regions, the highest prevalence rate 
was found in northern and eastern parts, while the lowest in western territories. Further analyzes are 
needed to compare it with the previous epidemiological data in the country, as well as an analysis for 
possible environmental effects for the low incidence rate, compared to those from literature. 
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INTRODUCTION
Thyroid carcinomas (TC) are predomi-
nant type of endocrine tumors, partici-
pating with around 1 % of all endocrine 
malignancies 1-5. According to data, pub-
lished in Cancer Research (UK), American 
Cancer Society and numerous studies, 
continuous increase in incidence rate of 
TC is detected. Thyroid carcinomas (TC) 
are heterogeneous group of neoplasm. 
According to histopathological features 
TC are classified as differentiated thyroid 
carcinomas including Papillary thyroid 
carcinoma (PTC) and Follicular thyroid 
carcinoma (FTC) and poorly differenti-
ated Anaplastic carcinoma (ATC), rare-
ly but with unfavorable prognosis and 
average survival time of only 6 months. 
Separate type of TC is Medullary thyroid 
carcinoma (MTC) arising from calcitonin 
producing C – cells and very rare are in-
tra-thyroid lymphomas originating from 
intra-thyroid lymph tissue and sarcomas 
arising from intra-thyroid connective 
tissue 6-8. Epidemiological studies have 
shown that almost all increases in inci-
dence rate were due to increase of differ-
entiated thyroid carcinomas, especially 
small PTC. Important observation from 
epidemiological data was that besides 
increase of the incidence rate, there 
was stable specific mortality rate of the 
disease. Scientific explanations for this 
global epidemiological trend are divided 
between possible over-diagnosis effect of 
thyroid micro-carcinomas, usually with 
indolent nature and possible increased 
exposition to some environmental fac-
tors promoting oncogenesis. Epidemio-
logical studies conducted from different 
authors and from different countries in 
almost all continents suggest significant 
increase in incidence rate of differenti-
ated thyroid carcinomas 9,10. Pelegriti 
et al., in their study concluded that in-
crease incidence is almost entirely due 
to increase in incidence of papillary his-
totype, with no significant change for the 
follicular, medullary or anaplastic histo-
types 11.
Because of lack of published papers re-
lated to the epidemiological data for TC 
in the last two decades in our country 
after introduction of corrected Iodine 
prophylaxis program with new higher 
Iodine supplementation in 1999, we have 
set as objective of our study to analyze 
epidemiological trends for period after 
establishing new Iodine salt supplemen-
tation. The aim of our study is to present 
the incidence and the prevalence rate of 
TC in R Macedonia for the period 1999-
2010, related to geographic and ethnic 
distribution. 
MATERIALS AND METHODS
A retrospective analysis of medical data 
from medical histories of all diagnosed and 
treated thyroid carcinomas at Institute of 
Pathophysiology and Nuclear Medicine 
for period 1999 – 2010 was performed. For 
analyzed period our Institute was the only 
nuclear medicine center in the country 
performing treatment of TC with 131I and 
registered data are representative for epi-
demiological analysis for the whole popu-
lation. Total number of diagnosed patients 
with TC for above mentioned period were 
registered and evaluated for their demo-
graphic characteristics. Using data from 
Statistical State Office for census in 1994 
and 2002 we have calculated yearly inci-
dence rate per 100.000 citizens and prev-
alence rate for period 1999-2010. Regional 
distribution of thyroid carcinomas in Mac-
edonia was also analyzed. Statistical analy-
sis was performed on incidence and preva-
lence rate in eight geographical regions of 
the whole country using official data from 
the Republic State Statistical Office and 
according to the last evidence the territo-
ry of R Macedonia is divided into 8 regions 
(Vardar, East, Southwest, Southeast, Pel-
agonia, Polog, Northeast and Skopje). Ac-
cording to data from the State Statistical 
Office, from 2010  and from statistical pop-
ulation data from 1994 and 2002, the prev-
alence rate for eight geographical regions 
was calculated 12. Epidemiological trends 
among the ethnic groups living in our 
country were evaluated by quantification 
of the yearly incidence and prevalence rate 
for appropriate period among three major 
ethnic groups living in our country, Mace-
donians, Albanians and Others (including 
Serbs, Turks, Bosnian, Romani and etc.).
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Figure 1  Annual incidence rate per 100.000 (1999-2010)
Results
During the period 1999 – 2010 204 pa-
tients with TC were registered of the 
total population of 2.022.547 at the ter-
ritory of 25 713 km2 and according to 
histopathology reports from all 204 TC 
only 9,8% were small tumors, less than 
15 mm. The most frequently diagnosed 
tumors were 15–50 mm in diameter 
(42,65%). Annual incidence rate showed 
continuously higher incidence rate of 
TC in the period 2006-2010 with mean 
incidence rate of 0,98/105, comparing 
with lower incidence rate for previous 
period from 1999 till 2005 when average 
incidence was 0,75/105. The exceptions 
were noticed in 2000 with the highest 
(1.18/105) and 2003 with the lowest inci-
dence rate (0,49/105) (Figure 1).
The prevalence rate for the period 1999 
– 2010 was 10,15/105 with 11 registered 
disease specific deaths from the total of 
204 diagnosed TC – mean mortality rate 
was 0,044/105 (Figure 2). 
Figure 2  Annual number of deaths from TC (1999-2010)
Regional distribution of TC in R Mace-
donia was also analyzed. According to 
the analysis of eight regions: the high-
est prevalence of TC was registered 
in Skopje region (12,7/105) followed by 
the East region (11,6/105), Northeast re-
gion (11,5/105), and Southwest region 
(9,5/105). The lowest prevalence rate was 
registered in Polog (3,5/105), Southeast 
(4,1/105), Pelagonia region (5,1/105) and 
central Vardar region (7,2/105 ) (Figure 3)
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Figure 3  Regional prevalence rate of thyroid carcinoma
Results indicate quite similar incidence 
and prevalence rate among the three 
ethnic groups (Figure 4). Prevalence rate 
for Macedonians and Albanians for this 
12-year period is the same and accounts 
10,02/105 and slightly higher for other 
ethnic groups (0,67/105). 
Figure 4  Incidence rate per 100.000 in different ethnic groups
Due to lack of published papers in 
the last 15 years about epidemiologi-
cal trends in TC in Macedonia and the 
lack of cancer register, we decided to 
perform statistical analysis in order to 
analyze statistical trends in TC. Our 
study revealed total number of 204 TC 
and prevalence rate of 10.15/100.000 
for the period 1999-2010. Statistical 
analysis detected increase in incidence 
rate from 0,49/100.000 in 2003 to 1,09 
in 2006 and 0,79/100.000 in 2010, but 
the highest number of diagnosed cases 
was in 2000 with 1,18/100.000. 
United States National Cancer Insti-
tute’s Surveillance Epidemiology and 
End Results (SEER) dataset, registered 
change in annual incidence rate from 
5,9  up to 14,3 thyroid carcinomas per 
100.000 citizens for period 2005 - 2009 
13. One of the highest increase in in-
cidence rate was found in South Korea 
from 2000, when ultra-sonographic 
(US) screening for thyroid nodules be-
Discussion
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came frequently preformed and signif-
icant increase in annual incidence rate 
was registered from 10 up to 70 cases 
per 100 000 individuals 14. Cancer Re-
search (UK) published detailed statisti-
cal data about incidence rates and from 
2.5/100.000 in 1999, registered continu-
ous increase to 4,5/100.000 in 2010 15. 
We have compared results with statisti-
cal data for our population from previ-
ous study for the period 1966 – 1980 (15 
years) when total number of 107 thyroid 
carcinomas were diagnosed and preva-
lence rate of 6,5/105 16. Epidemiological 
data indicate increase of TC in our pop-
ulation when comparing the two dec-
ade period from 6.5/105 to 10.15/105 and 
one of the reasons for this increase is 
probably due to the improvement of di-
agnostic methodology and widespread 
introduction of US in routine clinical 
examination.
Great divergence exists in observations 
from different epidemiological studies 
and our analysis. According to our data 
Macedonia has still very low incidence 
and prevalence rate comparing with 
data from literature. This discrepan-
cy may be result of low diagnostic ac-
curacy in small lesions, less than 1 cm, 
probably due to the fact that fine needle 
biopsy was preformed only in palpable 
nodules, without US guidance. Pelegriti 
et al., C. La Vecchia et al. in their studies 
suggest that the increase in incidence 
rate of thyroid carcinomas is mostly in 
detection of small, less than 1 cm thy-
roid carcinomas 13,15,17. Many studies 
indicate that detection of non-palpable 
thyroid nodules has increased with wid-
er application of US and other imaging 
modalities 18. Introduction of US FNAB 
lead to earlier detection of small mi-
cro-carcinomas. However, FNA cytolo-
gy has limitation due to non-diagnostic 
results, which according some studies 
range from 6,4% to 33,6%  19.
Our study results indicate that, in our 
population, the incidence rate of small-
er tumors (<15 mm) is only 9.8% of all 
diagnosed TC and is lower compared to 
data from other studies. Many reports 
suggested that spread of ultrasound 
guided fine needle aspiration biopsy 
(US-FNAB) facilitated the detection of 
small TC 20. Regardless this diagnostic 
method, it has been suggested that con-
stantly increasing incidence is present 
in general population 21. 
Besides improved diagnostic sensitiv-
ity there may be some other reasons 
for differences in epidemiology, like 
genetic differences and environmental 
influences 13, 22, 23. Such distinctions 
may result from multiple environmen-
tal factors like differences in iodine 
intake, irradiation exposition, expo-
sure to different chemical elements 
and compounds through soil, water 
and food intake. One well-known risk 
factor is neck irradiation exposition in 
childhood, unfortunately recognized 
after application of local irradiation 
treatment of the head and neck for in-
fection, inflammation of tonsil and na-
sopharyngeal region and in therapy of 
acne and thymus in period 1940-1950, 
later confirmed after Hiroshima bomb-
ing and Chernobyl nuclear power plant 
accident. Increased incidence rate was 
detected even in the first 3-4 years after 
the accident, especially in the young-
est population at the age group up to 4 
years 24, 25. In our study this risk fac-
tor was very low because of well-known 
facts about the effect of radiation ex-
position in early childhood, only small 
possible effect may be from Chernobyl 
accident which happened in 1986, or 13 
years before starting our analysis. 
The second well-known fact is that low 
but also high intake of iodine may re-
sult in changes of TSH, which may be 
promoting factor in tumor-genesis. Ex-
perimental animal studies showed that 
both conditions could be stimulating 
cancerogenic factors. Territory of R 
Macedonia was iodine deficient region 
till 1956 when iodine prophylaxis pro-
gram was started with introduction of 
salt iodination with 10mg KJ /1kg salt 
till 1999 when second program was ini-
tiated with 20 - 30 mg KJO3/1 kg salt. In 
2003 the expert team by WHO, UNICEF, 
ICCID and National Committee con-
ducted evaluation and concluded in 
their final report that iodine deficiency 
in R Macedonia was corrected 26. 
Many studies indicate higher incidence 
rate in volcanic territories. Malandrino 
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et al., conducted analysis of regional in-
cidence of thyroid carcinomas in territo-
ry of Sicily revealing significantly higher 
incidence rate in volcanic territories in 
the surrounding area of volcano Ethna. 
Authors evaluated possible etiopatho-
genetic association with many-fold in-
creased presence of some compunds 
and elements in drinking water, soil 
and food, like for increased presence 
of microelement Vanadium in drinking 
water in surrounding regions near vol-
cano Etna. Vanadium has potential ef-
fect on thyroid function and cell prolif-
eration 27-29. Uthus and Nielsen (1990) 
conducted animal experimental studies 
on rats and detected that Vanadium has 
effect on iodine metabolism and thyroid 
function by reducing the activity of thy-
roid peroxidase and Zhang et al.,(2001); 
Ingram et al. (2003) reported  possible 
mitogenic effect through stimulating 
activity of unknown growth factor 28. 
High prevalence TC rate is detected in 
volcano islands, Hawaii, Island, Iceland, 
New Caledonia 14. 
We analyzed differences in incidence 
rate in eight regions in R Macedonia 
and detected different incidence rate 
with the highest incidence rates in 
Skopje as north region, Northeast, East 
and Southwest regions, (12,7 …11,5/105) 
and Polog, Pelagonia and Southeast re-
gion with the lowest number of diag-
nosed TC cases. Last recent geothermal 
activity on the Balkans was described in 
Duvalo, near the village of Kosel located 
in the Southwest region, recognized as 
active geothermal surface feature and 
releasing occasionally gaseous carbon 
dioxide and hydrogen sulfide. Our data 
didn’t reveal extraordinary increase in 
incidence rate in Southwest region com-
paring to other regions in our country. 
We have also evaluated the incidence 
rate among different ethnic groups in 
our country. Significant difference in 
incidence among distinct ethnicities 
was described in literature, like higher 
incidence rate in Caucasian population 
in comparison to Afro-American and 
Latin population in the USA. According 
to the global available data the highest 
incidence rate was detected in Korea 
and islands in the South Pacific, like 
volcano islands, Hawaii, Island, Iceland, 
New Caledonia, Tahiti and the lowest 
incidence rate in Africa and Caribbean 
archipelago 13, 14, 28. Interesting fact 
was two-fold greater incidence in Jap-
anese and Chinese population living in 
America than in native population from 
their original countries. Differences are 
probably due to the external influences, 
but genetic factors could not be exclud-
ed 13, 29. Statistical data in our analy-
sis didn’t reveal significant differences 
among the evaluated ethnic groups, 
which showed very similar prevalence 
rate for Macedonians and Albanians 
and for the third group consisting of 
other ethnicities living in R Macedonia. 
Conclusion
According to the analyzed data from pa-
tients with thyroid carcinomas for peri-
od 1999–2010, it can be concluded that 
there was increase in incidence and 
prevalence rate in comparison to the 
previously observed period. Evaluation 
of statistical parameters among differ-
ent ethnicities in our country didn’t 
reveal significant differences among 
evaluated groups. Analysis of distribu-
tion of thyroid carcinomas in eight re-
gions showed the highest prevalence 
in northern and eastern regions of our 
country, while the lowest number of 
diagnosed patients was registered in 
western regions. The highest preva-
lence rates were registered in Skopje, 
East and Northeast region. Mostly diag-
nosed tumors were 15–50 mm in diam-
eter. Our incidence rate is still very low 
in comparison to data from other Eu-
ropean and American studies, probably 
due to the low detection rate of carci-
nomas less than 15mm in diameter. One 
possible explanation could be the fact 
that ultrasound guided biopsy was still 
not introduced in diagnostic algorithm 
for analyzed period and free hand biop-
sy was performed in lesions that were 
palpable. Further studies are needed 
to evaluate other potential factors for 
low number of diagnosed thyroid carci-
nomas, such as iodine intake and other 
environmental factors.
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